Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?

A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine. Interview-related links: Physician’s First Watch coverage of the statement Link to the statement, as published in Circulation News-related links: Lancet retracts 1998 paper linking MMR vaccination and autism Use prefilled Sanofi Pasteur N1N1 vaccines before mid-February JAMA study on proteinuria If you’d like to contact Clinical Conversations, call 1-617-440-4374 or write to [email protected] The post Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks? first appeared on Clinical Conversations.